[1]Berger[JournalfurpraktischeChemie(Leipzig1954),1939,vol.<2>152,p.267,314]
[2]CurrentPatentAssignee:GUIZHOUUNIVERSITY-CN108997253,2018,A
[3]Wu,Dehua;Song,Jintong;Qu,Lang;Zhou,Weilan;Wang,Lei;Zhou,Xiangge;Xiang,Haifeng[Chemistry-AnAsianJournal,2020,vol.15,#20,p.3370-3378]
[4]Hou,Shuaitao;Xie,Dewen;Yang,Jingxin;Niu,Xue;Hu,Deyu;Wu,Zhibing[ChemicalBiologyandDrugDesign,2021,vol.98,#1,p.166-174]
[5]CurrentPatentAssignee:GUIZHOUUNIVERSITY-CN113563281,2021,A
[1]Curtius;Mueller[ChemischeBerichte,1901,vol.34,p.2796]
[2]Cave;Galons;Miocque;Rinjard;Tran;Binet[EuropeanJournalofMedicinalChemistry,1990,vol.25,#1,p.75-79]
[3]Masuyama,Araki;Tsuchiya,Kikuo;Okahara,Mitsuo[BulletinoftheChemicalSocietyofJapan,1985,vol.58,#10,p.2855-2859]
[1]Galons;Cave;Miocque;Rinjard;Tran;Binet[EuropeanJournalofMedicinalChemistry,1990,vol.25,#9,p.785-788]
[1]Galons;Cave;Miocque;Rinjard;Tran;Binet[EuropeanJournalofMedicinalChemistry,1990,vol.25,#9,p.785-788]
Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
Journal: Bioorganic & medicinal chemistry letters 20101101
Title: Rational design of new antituberculosis agents: receptor-independent four-dimensional quantitative structure-activity relationship analysis of a set of isoniazid derivatives.
Journal: Journal of medicinal chemistry 20040715
Title: Chemotherapy of experimental tuberculosis. V. Isonicotinic acid hydrazide (nydrazid) and related compounds.
Journal: American review of tuberculosis 19520401
